Vaccine News and Research

Latest Vaccine News and Research

Researchers identify novel genes that make some children cope with malaria

Researchers from Sainte-Justine University Hospital Center and University of Montreal have identified several novel genes that make some children more efficient than others in the way their immune system responds to malaria infection.

12 Sep 2012

Researchers investigate whether altruism influences parental decisions to vaccinate children

As outbreaks of preventable diseases such as whooping cough and measles increase in the United States, researchers from the Regenstrief Institute and Indiana University School of Medicine are investigating whether altruism, known to influence adults' decisions to immunize themselves, influences parental decisions to vaccinate their children.

12 Sep 2012

Individuals without capacity excluded from potentially beneficial trials

Individuals who lack the capacity to consent to taking part in clinical trials could be missing out on the opportunity to receive potentially beneficial interventions, shows UK research.

11 Sep 2012

First Edition: September 11, 2012

Today's headlines explore how, based on his recent comments, Mitt Romney's health law replacement goals could become tricky.

11 Sep 2012

Dengue vaccine breakthrough

Results of the first ever trial to show that a safe and effective dengue vaccine may be possible are published Online First in The Lancet.

11 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

Most Asian countries fail to include rotavirus vaccine in national immunization programs citing cost as barrier

"Most countries in Asia have yet to make the rotavirus vaccine part of their national immunization program (NIP), despite a World Health Organization (WHO) recommendation to do so," IRIN reports.

11 Sep 2012

CSL Biotherapies receives U.S. Government contract to supply pandemic vaccine antigens

CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced it has been awarded a contract by the United States (U.S.) Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile.

11 Sep 2012

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Sangamo BioSciences, Inc. announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach designed to generate a "functional cure" for HIV/AIDS, were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

11 Sep 2012

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.

10 Sep 2012

Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston

"With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers of AIDS Vaccine 2012 say," the Center for Global Health Policy's "Science Speaks" blog reports.

7 Sep 2012

Research roundup: Reducing risk in shared savings programs

The Design And Application Of Shared Savings Programs: Lessons From Early Adopters --"Shared savings programs reward providers for holding spending below specific targets, thus introducing a level of financial accountability not present in strictly volume-based payment models, such as fee-for-service," researchers write.

7 Sep 2012

Uganda launches vaccination campaign against cervical cancer

"The government of Uganda has launched a vaccination campaign against cervical cancer -- the most common type of cancer among Ugandan women -- but there are already fears a nationwide rollout might be jeopardized by lack of funds," IRIN reports.

7 Sep 2012

History of TB policy shows need for care, investment equity in developed, developing countries

In a 200th anniversary article for the New England Journal of Medicine, Salmaan Keshavjee of the Department of Global Health and Social Medicine at Harvard Medical School and Paul Farmer of Partners in Health "seek to elucidate the reasons for the anemic response to drug-resistant tuberculosis [TB] by examining the recent history of tuberculosis policy," they write.

7 Sep 2012

Sleep disruptions may be among the first signs of Alzheimer's

Sleep disruptions may be among the earliest indicators of Alzheimer's disease, scientists at Washington University School of Medicine in St. Louis report Sept. 5 in Science Translational Medicine.

6 Sep 2012

Cholera vaccine offers herd immunity, study from Zanzibar shows

"Cholera vaccine gives indirect protection to unvaccinated people in communities where a substantial fraction of the population gets the vaccine," according to a study from the island of Zanzibar in East Africa, published in the Lancet on Tuesday, NPR's "Shots" blog reports.

6 Sep 2012

WHO releases dengue strategy report, sets goal of cutting related deaths in half by 2020

"Saying dengue virus infections and deaths have mushroomed in recent years, the World Health Organization (WHO) recently released a strategy report that sets a goal of cutting deaths in half and reducing cases by 25 percent over the next eight years," CIDRAP reports.

6 Sep 2012

Pakistan official says progress made in vaccinating thousands of children against polio in tribal area

"Pakistan Tuesday claimed progress in vaccinating thousands of children against polio in a tribal area bordering Afghanistan which had been inaccessible due to unrest for about three years," Agence France-Presse reports.

6 Sep 2012

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.

6 Sep 2012

People need to protect themselves against West Nile virus

As this year's threat from the West Nile virus continues, one infectious diseases expert at the University of Alabama at Birmingham says a vaccine is not in our near future, so people need to protect themselves.

5 Sep 2012